54478-3 |
Dicarboxypalmitoylcarnitine (C16-DC) |
SCnc |
Amnio fld |
Pt |
Qn |
|
|
ACTIVE |
Dicarboxypalmitoylcarnitine (C16-DC) [Moles/volume] in Amniotic fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54478-3 |
|
|
|
|
Both |
|
|
|
0 |
Dicarboxypalmitoylcarn Amn-sCnc |
|
|
|
N |
|
AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; C16DC; C16-DC; Chemistry; Hexadecanediolycarnitine; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; thapsoyl carnitine |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54479-1 |
Dicarboxypalmitolycarnitine (C16-DC) |
SCnc |
Bld.dot |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Dicarboxypalmitoylcarnitine (C16-DC) [Molecules/volume] in Blood dot (filter paper) |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54479-1 |
|
|
|
|
Both |
|
|
|
0 |
Deprecated Dicarboxypalmitoylcarn Bld.do |
|
|
|
N |
|
Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood |
2.7 |
2.27 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
5448-6 |
CD20 |
ACnc |
WBC |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated CD20 cells/100 cells in Blood |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CELLMARK |
|
5448-6 |
|
|
|
|
|
|
|
|
0 |
Deprecated CD20 WBC-aCnc |
|
|
|
|
|
Arbitrary concentration; B1; B-1; Bp35; CELL MARKERS; Leu16; Leu-16; Leukocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells |
2.69 |
1 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
54480-9 |
Dicarboxypalmitoylcarnitine (C16-DC) |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Dicarboxypalmitoylcarnitine (C16-DC) [Moles/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54480-9 |
|
|
|
|
Both |
|
|
|
0 |
Dicarboxypalmitoylcarn Ur-sCnc |
|
|
|
N |
|
C16DC; C16-DC; Chemistry; Hexadecanediolycarnitine; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; thapsoyl carnitine; UA; UR; Urn |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54481-7 |
Dicarboxystearoylcarnitine (C18-DC)/Creatinine |
SRto |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Dicarboxystearoylcarnitine (C18-DC)/Creatinine [Molar ratio] in Urine |
|
MIN |
DefinitionDescription |
|
|
umol/mmol creatinine |
|
|
|
|
|
|
CHEM |
|
54481-7 |
|
|
|
|
Both |
|
|
|
0 |
Dicarboxystearoylcarn/Creat Ur-sRto |
|
|
|
N |
|
C18DC; C18-DC; Chemistry; CR; Crea; Creat; Dicarboxy stearoyl carnitine; Dicarboxy stearoylcarnitine; Dicarboxylic carnitine; octadecanedioyl carnitine; octadecanedioylcarnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/mmol{creat} |
|
|
|
0 |
54482-5 |
Dicarboxystearoylcarnitine (C18-DC) |
SCnc |
CSF |
Pt |
Qn |
|
|
ACTIVE |
Dicarboxystearoylcarnitine (C18-DC) [Moles/volume] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54482-5 |
|
|
|
|
Both |
|
|
|
0 |
Dicarboxystearoylcarn CSF-sCnc |
|
|
|
N |
|
C18DC; C18-DC; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Dicarboxy stearoyl carnitine; Dicarboxy stearoylcarnitine; Dicarboxylic carnitine; Level; octadecanedioyl carnitine; octadecanedioylcarnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54483-3 |
Dicarboxystearoylcarnitine (C18-DC) |
SCnc |
Amnio fld |
Pt |
Qn |
|
|
ACTIVE |
Dicarboxystearoylcarnitine (C18-DC) [Moles/volume] in Amniotic fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54483-3 |
|
|
|
|
Both |
|
|
|
0 |
Dicarboxystearoylcarn Amn-sCnc |
|
|
|
N |
|
AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; C18DC; C18-DC; Chemistry; Dicarboxy stearoyl carnitine; Dicarboxy stearoylcarnitine; Dicarboxylic carnitine; Level; octadecanedioyl carnitine; octadecanedioylcarnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54484-1 |
Octadecanedioylcarnitine (C18-DC) |
SCnc |
Bld.dot |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Dicarboxystearoylcarnitine (C18-DC) [Molecules/volume] in Blood dot (filter paper) |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54484-1 |
|
|
|
|
Both |
|
|
|
0 |
Deprecated Dicarboxystearoylcarn Bld.Dot |
|
|
|
N |
|
Blood; Chemistry; DBS; Dicarboxylic carnitine; Dried blood spot; Filter paper; FP; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood |
2.7 |
2.27 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
54485-8 |
Dicarboxystearoylcarnitine (C18-DC) |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Dicarboxystearoylcarnitine (C18-DC) [Moles/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54485-8 |
|
|
|
|
Both |
|
|
|
0 |
Dicarboxystearoylcarn Ur-sCnc |
|
|
|
N |
|
C18DC; C18-DC; Chemistry; Dicarboxy stearoyl carnitine; Dicarboxy stearoylcarnitine; Dicarboxylic carnitine; Level; octadecanedioyl carnitine; octadecanedioylcarnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54486-6 |
Glucose |
MCnc |
Water |
Pt |
Qn |
|
|
ACTIVE |
Glucose [Mass/volume] in Water |
|
MIN |
DefinitionDescription |
|
|
g/L |
|
|
|
|
|
|
CHEM |
|
54486-6 |
|
|
|
|
Both |
|
|
|
0 |
Glucose Wat-mCnc |
|
|
|
N |
|
Chemistry; Glu; Gluc; Glucoseur; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Wat |
2.7 |
2.27 |
|
|
|
|
|
|
|
g/L |
|
|
|
0 |
54487-4 |
Glucose |
SCnc |
Water |
Pt |
Qn |
|
|
ACTIVE |
Glucose [Moles/volume] in Water |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHEM |
|
54487-4 |
|
|
|
|
Both |
|
|
|
0 |
Glucose Wat-sCnc |
|
|
|
N |
|
Chemistry; Glu; Gluc; Glucoseur; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Wat |
2.7 |
2.27 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
54488-2 |
Pimeloylcarnitine (C7-DC)/Creatinine |
SRto |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Pimeloylcarnitine (C7-DC)/Creatinine [Molar ratio] in Urine |
|
MIN |
DefinitionDescription |
|
|
umol/mmol creatinine |
|
|
|
|
|
|
CHEM |
|
54488-2 |
|
|
|
|
Both |
|
|
|
0 |
Pimeloylcarn/Creat Ur-sRto |
|
|
|
N |
|
Chemistry; CR; Crea; Creat; Dicarboxylic carnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/mmol{creat} |
|
|
|
0 |
54489-0 |
Phosphoserine |
SCnc |
Bld.dot |
Pt |
Qn |
|
|
ACTIVE |
Phosphoserine [Moles/volume] in DBS |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54489-0 |
|
|
|
|
Both |
|
|
|
0 |
Phosphoserine DBS-sCnc |
|
|
|
N |
|
Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Level; Point in time; PS; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
5449-4 |
CD21 |
ACnc |
WBC |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated CD21 cells/100 cells in Blood |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CELLMARK |
|
5449-4 |
|
|
|
|
|
|
|
|
0 |
Deprecated CD21 WBC-aCnc |
|
|
|
|
|
Arbitrary concentration; B2; B-2; C3d receptor; CELL MARKERS; CR2; EBV-R; Epstein Barr virus receptor; Leukocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells |
2.69 |
1 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
54490-8 |
Pipecolate |
SCnc |
Amnio fld |
Pt |
Qn |
|
|
ACTIVE |
Pipecolate [Moles/volume] in Amniotic fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54490-8 |
|
|
|
|
Both |
|
|
|
0 |
Pipecolate Amn-sCnc |
|
|
|
N |
|
AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Chemistry; Level; Pipa; Pipecolic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54491-6 |
Alanine aminotransferase |
CCnc |
Periton fld |
Pt |
Qn |
|
|
ACTIVE |
Alanine aminotransferase [Enzymatic activity/volume] in Peritoneal fluid |
|
MIN |
DefinitionDescription |
|
|
arb U/L |
|
|
|
|
|
|
CHEM |
|
54491-6 |
|
|
|
|
Both |
|
|
|
0 |
ALT Prt-cCnc |
|
|
|
N |
|
Ala; Alanine transaminase; ALAT; Alpha alanine; ALT; Ascites; Ascitic fluid; Ascitis; Catalytic Concentration; Chemistry; Glutamic-pyruvic transferase; L-alanine; Peritoneal fluid; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random; SGPT |
2.7 |
2.27 |
|
|
|
|
|
|
|
U/L |
|
|
|
0 |
54492-4 |
Alanine aminotransferase |
CCnc |
Plr fld |
Pt |
Qn |
|
|
ACTIVE |
Alanine aminotransferase [Enzymatic activity/volume] in Pleural fluid |
|
MIN |
DefinitionDescription |
|
|
arb U/L |
|
|
|
|
|
|
CHEM |
|
54492-4 |
|
|
|
|
Both |
|
|
|
0 |
ALT Plr-cCnc |
|
|
|
N |
|
Ala; Alanine transaminase; ALAT; Alpha alanine; ALT; Catalytic Concentration; Chemistry; Glutamic-pyruvic transferase; Hepatology; L-alanine; Liver; Lung; Pleural; Pleural fluid; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; SGPT; thoracentesis fluid |
2.7 |
2.27 |
|
|
|
|
|
|
|
U/L |
|
|
|
0 |
54493-2 |
Allantoine |
SRat |
Urine |
24H |
Qn |
Electrophoresis |
|
ACTIVE |
Allantoine [Moles/time] in 24 hour Urine by Electrophoresis |
|
MIN |
DefinitionDescription |
|
|
mmol/24 H |
|
|
|
|
|
|
CHEM |
|
54493-2 |
|
Electrophoresis |
|
|
Both |
|
|
|
0 |
Allantoine 24h Ur Elph-sRate |
|
|
|
N |
|
1 day; 24 hours; 24HR; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; QNT; Quan; Quant; Quantitative; sRate; Substance rate; UA; UR; Urn |
2.7 |
2.27 |
|
|
|
|
|
|
|
mmol/(24.h) |
|
|
|
0 |
54494-0 |
Chloride |
MCnc |
Water |
Pt |
Qn |
|
|
ACTIVE |
Chloride [Mass/volume] in Water |
|
MIN |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
CHEM |
|
54494-0 |
|
|
|
|
Both |
|
|
|
0 |
Chloride Wat-mCnc |
|
|
|
N |
|
Chemistry; Cl; Cl-; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Wat |
2.7 |
2.27 |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
54495-7 |
Glucose^post dialysis |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Glucose [Moles/volume] in Serum or Plasma --post dialysis |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHEM |
|
54495-7 |
|
|
|
|
Both |
|
|
|
0 |
Glucose p dialysis SerPl-sCnc |
|
|
|
N |
|
After; Chemistry; Dialy; Glu; Gluc; Glucoseur; Kidney; Level; Nephrology; p dialysis; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Renal; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.7 |
2.27 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
54496-5 |
Glucose^5th specimen post XXX challenge |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Glucose [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHAL |
|
54496-5 |
|
|
|
|
Both |
|
|
|
0 |
Glucose sp5 p chal SerPl-sCnc |
|
|
|
N |
|
After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp5; sp5 p chal; Spec; SR; Substance concentration |
2.7 |
2.27 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
54497-3 |
Glucose^6th specimen post XXX challenge |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Glucose [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHAL |
|
54497-3 |
|
|
|
|
Both |
|
|
|
0 |
Glucose sp6 p chal SerPl-sCnc |
|
|
|
N |
|
After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp6; sp6 p chal; Spec; SR; Substance concentration |
2.7 |
2.27 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
54498-1 |
Glucose^7th specimen post XXX challenge |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Glucose [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHAL |
|
54498-1 |
|
|
|
|
Both |
|
|
|
0 |
Glucose sp7 p chal SerPl-sCnc |
|
|
|
N |
|
^7th spec pst XXX chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp7; sp7 p chal; Spec; SR; Substance concentration |
2.7 |
2.27 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
54499-9 |
Glucose^8th specimen post XXX challenge |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Glucose [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHAL |
|
54499-9 |
|
|
|
|
Both |
|
|
|
0 |
Glucose sp8 p chal SerPl-sCnc |
|
|
|
N |
|
After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp8; sp8 p chal; Spec; SR; Substance concentration |
2.7 |
2.27 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
545-4 |
Bacteroides melaninogenicus Ag |
PrThr |
XXX |
Pt |
Ord |
IF |
|
ACTIVE |
Bacteroides melaninogenicus Ag [Presence] in Specimen by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
545-4 |
|
IF |
|
|
Both |
|
|
|
0 |
B melaninogenicus Ag Spec Ql IF |
|
|
|
|
|
ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; B melaninogenicus; DFA; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Melanogen; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; Time Resolved Fluorescence; To be specified in another part of the message; TRF; Unspecified |
2.69 |
1 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |